97 related articles for article (PubMed ID: 1666294)
21. Gene expression and differentiation in F9 mouse embryonal carcinoma cells.
Sleigh MJ
Biochem Soc Symp; 1989; 55():1-12. PubMed ID: 2619760
[TBL] [Abstract][Full Text] [Related]
22. EIa-mediated transactivation of the adenovirus EIIa early promoter is restricted in undifferentiated F9 cells.
Boeuf H; Jansen-Durr P; Kédinger C
Oncogene; 1990 May; 5(5):691-9. PubMed ID: 2161097
[TBL] [Abstract][Full Text] [Related]
23. Decrease in the c-myb gene transcript during differentiation of mouse teratocarcinoma stem cells.
Fukuda M; Ikuma S; Setoyama C; Shimada K
Biochem Int; 1987 Jul; 15(1):73-9. PubMed ID: 2840075
[TBL] [Abstract][Full Text] [Related]
24. [Noninduced single-stranded breaks in DNA in murine F9 teratocarcinoma cells].
Kisliakova TV; Kustova ME; Lianguzova MS; Malashcheva AB; Strunnikova MA; Suchkova IO; Pospelov VA; Patkin EL
Tsitologiia; 2000; 42(11):1060-8. PubMed ID: 11204650
[TBL] [Abstract][Full Text] [Related]
25. Role for up-regulated ganglioside biosynthesis and association of Src family kinases with microdomains in retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
Sato T; Zakaria AM; Uemura S; Ishii A; Ohno-Iwashita Y; Igarashi Y; Inokuchi J
Glycobiology; 2005 Jul; 15(7):687-99. PubMed ID: 15788739
[TBL] [Abstract][Full Text] [Related]
26. A mouse pluripotent embryonal stem cell line stage-specifically regulates expression of homeo-box containing DNA sequences during differentiation in vitro.
Eistetter HR
Eur J Cell Biol; 1988 Feb; 45(2):315-21. PubMed ID: 2452735
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
Andrews PW; Damjanov I; Berends J; Kumpf S; Zappavigna V; Mavilio F; Sampath K
Lab Invest; 1994 Aug; 71(2):243-51. PubMed ID: 7521445
[TBL] [Abstract][Full Text] [Related]
28. A role for Indian hedgehog in extraembryonic endoderm differentiation in F9 cells and the early mouse embryo.
Becker S; Wang ZJ; Massey H; Arauz A; Labosky P; Hammerschmidt M; St-Jacques B; Bumcrot D; McMahon A; Grabel L
Dev Biol; 1997 Jul; 187(2):298-310. PubMed ID: 9242425
[TBL] [Abstract][Full Text] [Related]
29. Global gene expression patterns during differentiation of F9 embryonal carcinoma cells into parietal endoderm.
Harris TM; Childs G
Funct Integr Genomics; 2002 Aug; 2(3):105-19. PubMed ID: 12185458
[TBL] [Abstract][Full Text] [Related]
30. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
Andrews PW; Trinchieri G; Perussia B; Baglioni C
Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
[TBL] [Abstract][Full Text] [Related]
31. The adenovirus-5 12S E1a protein, but not the 13S induces expression of the endoA differentiation marker in F9 cells.
Velcich A; Ziff EB
Oncogene; 1989 Jun; 4(6):707-13. PubMed ID: 2543941
[TBL] [Abstract][Full Text] [Related]
32. [Mouse teratocarcinoma: differentiation in cultures of a multipotential primitive cell line (author's transl)].
Nicolas JF; Dubois P; Jakob H; Gaillard J; Jacob F
Ann Microbiol (Paris); 1975 Jan; 126(1):3-22. PubMed ID: 1103673
[TBL] [Abstract][Full Text] [Related]
33. [Growth and differentiation of human germ cell tumors: a possible model of embryogenesis].
Sekiya S
Hum Cell; 1995 Mar; 8(1):3-9. PubMed ID: 7669750
[TBL] [Abstract][Full Text] [Related]
34. [Differentiation of human germ cell tumor cells].
Hata J; Fujita H; Ikeda E; Matsubayashi Y; Kokai Y; Fujimoto J
Hum Cell; 1989 Dec; 2(4):382-7. PubMed ID: 2562098
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous differentiation in the colonies of a nullipotent embryonal carcinoma cell line (F9).
Zákány J; Burg K; Raskó I
Differentiation; 1984; 27(2):146-51. PubMed ID: 6479493
[TBL] [Abstract][Full Text] [Related]
36. Nullipotent teratocarcinoma cells acquire the pluripotency for differentiation by fusion with somatic cells.
Atsumi T; Shirayoshi Y; Takeichi M; Okada TS
Differentiation; 1982; 23(1):83-6. PubMed ID: 7152170
[TBL] [Abstract][Full Text] [Related]
37. Hybrids between F9 nullipotent teratocarcinoma and thymus cells produce multidifferentiated tumors in mice.
Rousset JP; Bucchini D; Jami J
Dev Biol; 1983 Apr; 96(2):331-6. PubMed ID: 6832476
[TBL] [Abstract][Full Text] [Related]
38. Hybrids of pluripotent and nullipotent human embryonal carcinoma cells: partial retention of a pluripotent phenotype.
Duran C; Talley PJ; Walsh J; Pigott C; Morton IE; Andrews PW
Int J Cancer; 2001 Aug; 93(3):324-32. PubMed ID: 11433395
[TBL] [Abstract][Full Text] [Related]
39. Formation of the annexin II2p112 complex upon differentiation of F9 teratocarcinoma cells.
Harder T; Thiel C; Gerke V
J Cell Sci; 1993 Apr; 104 ( Pt 4)():1109-17. PubMed ID: 8314895
[TBL] [Abstract][Full Text] [Related]
40. Cloning and characterization of keratin D, a murine endodermal cytoskeletal protein induced during in vitro differentiation of F9 teratocarcinoma cells.
Alonso A; Weber T; Jorcano JL
Rouxs Arch Dev Biol; 1987 Jan; 196(1):16-21. PubMed ID: 28305656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
